Jointown Pharmaceutical Group Co Ltd (600998) - Total Liabilities
Based on the latest financial reports, Jointown Pharmaceutical Group Co Ltd (600998) has total liabilities worth CN¥77.21 Billion CNY (≈ $11.30 Billion USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Jointown Pharmaceutical Group Co Ltd (600998) equity growth momentum to track the company's year-over-year net asset growth rate.
Jointown Pharmaceutical Group Co Ltd - Total Liabilities Trend (2007–2024)
This chart illustrates how Jointown Pharmaceutical Group Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See Jointown Pharmaceutical Group Co Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Jointown Pharmaceutical Group Co Ltd Competitors by Total Liabilities
The table below lists competitors of Jointown Pharmaceutical Group Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
CGN Power Co Ltd
F:94C
|
Germany | €329.44 Billion |
|
Fosun International Limited
F:FNI
|
Germany | €547.93 Billion |
|
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566
|
China | CN¥2.82 Billion |
|
Masan Group Corp
VN:MSN
|
Vietnam | ₫81.82 Trillion |
|
WSFS Financial Corporation
NASDAQ:WSFS
|
USA | $18.59 Billion |
|
Honeywell Automation India Limited
NSE:HONAUT
|
India | Rs17.66 Billion |
|
Aya Gold & Silver Inc
TO:AYA
|
Canada | CA$207.91 Million |
|
KINGSOFT C.H.LTD. DL-001
F:KS70
|
Germany | €17.42 Billion |
Liability Composition Analysis (2007–2024)
This chart breaks down Jointown Pharmaceutical Group Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Jointown Pharmaceutical Group Co Ltd stock valuation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.24 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.73 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.69 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Jointown Pharmaceutical Group Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Jointown Pharmaceutical Group Co Ltd (2007–2024)
The table below shows the annual total liabilities of Jointown Pharmaceutical Group Co Ltd from 2007 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥68.80 Billion ≈ $10.07 Billion |
+8.67% |
| 2023-12-31 | CN¥63.31 Billion ≈ $9.26 Billion |
-0.43% |
| 2022-12-31 | CN¥63.59 Billion ≈ $9.30 Billion |
+8.02% |
| 2021-12-31 | CN¥58.86 Billion ≈ $8.61 Billion |
+6.62% |
| 2020-12-31 | CN¥55.21 Billion ≈ $8.08 Billion |
+12.25% |
| 2019-12-31 | CN¥49.18 Billion ≈ $7.20 Billion |
+6.24% |
| 2018-12-31 | CN¥46.29 Billion ≈ $6.77 Billion |
+42.39% |
| 2017-12-31 | CN¥32.51 Billion ≈ $4.76 Billion |
+21.68% |
| 2016-12-31 | CN¥26.72 Billion ≈ $3.91 Billion |
+17.50% |
| 2015-12-31 | CN¥22.74 Billion ≈ $3.33 Billion |
+41.79% |
| 2014-12-31 | CN¥16.04 Billion ≈ $2.35 Billion |
+20.98% |
| 2013-12-31 | CN¥13.26 Billion ≈ $1.94 Billion |
+32.99% |
| 2012-12-31 | CN¥9.97 Billion ≈ $1.46 Billion |
+32.29% |
| 2011-12-31 | CN¥7.54 Billion ≈ $1.10 Billion |
+82.88% |
| 2010-12-31 | CN¥4.12 Billion ≈ $602.92 Million |
-25.02% |
| 2009-12-31 | CN¥5.50 Billion ≈ $804.09 Million |
+29.55% |
| 2008-12-31 | CN¥4.24 Billion ≈ $620.69 Million |
+34.95% |
| 2007-12-31 | CN¥3.14 Billion ≈ $459.94 Million |
-- |
About Jointown Pharmaceutical Group Co Ltd
Jointown Pharmaceutical Group Co., Ltd engages in pharmaceutical distribution and supply chain business in China and internationally. It is also involved in general agency brand promotion; pharmaceutical industrial self-production and OEM; and pharmaceutical new retail and ten-thousand store alliance plan businesses. In addition, the company provides medical health and technology value-added serv… Read more